CVS/pharmacy announced Thursday that it will launch three new exclusive beauty lines as part of an expansion into beauty categories — including naturals, therapeutics and clinically-proven products — that focuses on the intersection of health and beauty.
Remedies for conditions like hepatitis C, NASH (nonalcoholic steatohepatitis) and oncology will all help contribute to growth within the biotech sector, according to an analysis from Bloomberg Intelligence.
In light of the renewed discussions on the efficacy and safety of childhood vaccinations, The American Pharmacists Association issued a statement on the important role childhood and lifespan vaccinations play in protecting personal and public health.
Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.
DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.
Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023.